At the extraordinary general meeting in
Election of new board member
It was resolved in accordance with major shareholders' proposal to dismiss
Furthermore, it was resolved in accordance with major shareholders' proposal that
Changes to the articles of association
The general meeting resolved in accordance with the board of directors' proposal on changes to the Company's articles of association with respect to share capital and number of shares in §§ 4 and 5. According to the new articles of association the Company's share capital shall be not less than
Resolution on authorisation for the board of directors to resolve on issues of shares, warrants and/or convertibles
The general meeting resolved to authorise the board of directors to, on one or several occasions for the period until the next annual general meeting, with or without deviation from the shareholders' preferential rights, resolve on issue of shares, warrants and/or convertibles against cash payment and/or with provision of non-cash consideration or set-off or otherwise with conditions.
For issues carried out by virtue of this authorisation, neither the share capital nor the number of shares that are added, or which may be added upon exercise of issued warrants and/or convertibles, shall be able to generate a dilution exceeding 30 percent of the share capital and the number of shares based on the share capital and the number of shares in the Company at the time the authorisation is first exercised.
Please note that this is a translation for information purposes only. In the event of any discrepancies between the Swedish and English versions, the Swedish version shall prevail
The information was submitted for publication, through the agency of the contact person set out below, at
For more information:
Johan Rutgersson
johan@dewell.se
+46 708 157 200
About
https://news.cision.com/speqta-ab/r/report-from-the-extraordinary-general-meeting-in-speqta-ab--publ--on-2-february-2024,c3921662
https://mb.cision.com/Main/7124/3921662/2580269.pdf
https://news.cision.com/speqta-ab/i/speqta,c3263653
(c) 2024 Cision. All rights reserved., source